Vascular calcification inhibitors in chronic kidney disease
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
In-phase matrix profile: A novel method for the detection of major depressive disorder
Optical Real-Time Cardiorenal Toxin Uric Acid Measurement During Hemodialysis Using a Miniaturized Optical Sensor
Electroencephalography as an Objective Indicator of Stress
Hemodialysis Optical Monitoring Toward Greener Technology: A Potential for Water Saving Dialysis Treatment
Influence of Acute Mental Stress on the Forehead Photoplethysmographic Signal Waveform
Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements
Limiting exposure to radiofrequency radiation: the principles and possible criteria for health protection
Correlation between electroencephalographic markers in the healthy brain
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab